Evaluation of fibromyalgia frequency and quality of life in Notalgia paresthetica patients
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03027-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Nihal Sarı und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Bulancak State Hospital, Giresun, Turkey. nihal02_kyl@hotmail.com. Hauptthemen laut MEDLINE: Fibromyalgia, Quality of Life, Severity of Illness Index. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Giresun University.
Abstract (Originalsprache)
Based on the presence of chronic pain and the potential use of common treatment agents in Notalgia Paresthetica (NP) and Fibromyalgia Syndrome (FMS) for improvement, we aimed to investigate the frequency of FMS symptoms in NP patients and its impact on quality of life. This study is a case control cohort study including 26 patients diagnosed with NP and a total of 26 controls matched for age and gender. The 2016 revised fibromyalgia diagnostic criteria by the American College of Rheumatology (ACR) were used to inquire about FMS diagnosis criteria in the study. According to the 2016 ACR revised FMS diagnostic criteria, the frequency of FMS was significantly higher in the patient group (n = 9, 34.6%) compared to the control group (n = 2, 7.7%) (p = 0.042). The Wide Pain Index (WPI) score in the control group was 2.00 (3.25), while in the patient group, it was 4.00 (8.00), with a statistically significant difference between them (p < 0.035). Furthermore, significant statistical differences were found between the two groups in terms of Symptom Severity Scale (SSS), Fibromyalgia Score (FS), and FIQ (p < 0.035, p < 0.001, p < 0.001, respectively). In NP patients with accompanying FMS, Dermatology Life Quality Index was significantly more affected compared to those without FMS (p = 0.025). In conclusion, we recommend that NP patients be questioned about FMS, which is characterized by generalized pain, as well as regional neuropathic symptoms. Treatment success can be enhanced by using common agents in the treatment choice for accompanying FMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Bulancak State Hospital, Giresun, Turkey. nihal02_kyl@hotmail.com.
- Department of Dermatology and Venereology, Faculty of Medicine, Giresun University, Giresun, Turkey. nihal02_kyl@hotmail.com.
- Department of Dermatology and Venereology, Faculty of Medicine, Giresun University, Giresun, Turkey.
- The Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Giresun University, Giresun, Turkey.
Förderung
- Giresun University
Zitieren
APA
Sarı, N., Kulaklı, S., Oğuz, I. D., Akşan, B., & Sarı, İ. F. (2024). Evaluation of fibromyalgia frequency and quality of life in Notalgia paresthetica patients. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03027-8
Vancouver
Sarı N, Kulaklı S, Oğuz ID, Akşan B, Sarı İF. Evaluation of fibromyalgia frequency and quality of life in Notalgia paresthetica patients. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03027-8
BibTeX
@article{Sar2024,
author = {Sarı, Nihal and Kulaklı, Sevgi and Oğuz, Işıl Deniz and Akşan, Burak and Sarı, İlker Fatih},
title = {Evaluation of fibromyalgia frequency and quality of life in Notalgia paresthetica patients},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03027-8}
}
EUVIMED